Medicago ending its COVID-19 vaccine production in Quebec

Medicago announced on Thursday that it will be shutting down its COVID-19 vaccine project in Quebec. As a result, 586 jobs in the province will be affected. The closure comes as Medicago’s sole shareholder, the Japan-based Mitsubishi Chemical Group, decided to stop marketing the Covifenz vaccine.